Manish Gupta, M.D.

Education

• Fellowship in Medical Oncology and Hematology
  The University of Oklahoma, Oklahoma City, Oklahoma
• Residency in Internal Medicine
  The University of Oklahoma, Oklahoma City, Oklahoma
• Internship in Internal Medicine
  The University of Oklahoma, Oklahoma City, Oklahoma
• Medical Doctorate
  American University of the Caribbean

Accolades & Memberships

• American Association of Physician of Indian Origin
• American Medical Association
• American Society of Clinical Oncology
• Community Oncology Alliance
• D Magazine Best Doctor Dallas (2006 – 2013, 2015, 2018 – 2023)
• D Magazine Best Doctor in Collin County (2015, 2016, 2018, 2020 – 2023)
• Living Magazine Readers’ Choice Best Oncologist (2019)
• Texas Medical Association

Leadership and Committee Experience

• Area Medical Director, Plano West, Texas Oncology (2006 – 2022)
• Baylor Garland Family Practice Residency Program, Medical Education Committee (2004 – 2008)
• Board of Directors, Baylor Garland (2007 – 2009)
• Board of Directors, Texas Oncology (2008 – 2022)
• Chairman, Baylor Scott & White Quality Alliance, Oncology (2016 – 2017)
• Chairman, Department of Internal Medicine, Baylor Medical Center (2007 – 2009)
• Chairman, Oncology Committee, Baylor Scott & White Plano (2016)
• Chairman, Salary and Benefits Committee, Texas Oncology (2023 – present)
• Chief Fellow, Department of Hematology/Oncology, University of Oklahoma (2001 – 2002)
• Director, Oncology Quality Committee, Baylor Scott & White Plano (2006 – 2022)
• Management Executive Committee, Texas Oncology (2022 – present)
• Managing Medical Director, Northeast and DFW West Region, Texas Oncology (2023 – present)
• Medical Quality Committee, Baylor Garland (2005 – 2008)
• Operating Board, Texas Oncology (2021 – present)
• Pathway Exception Committee (2021 – present)
• Primary Investigator/Site Leader, Plano West Cancer Center Clinical Research Program (2005 – 2016)
• Regional Medical Director, Northeast Region, Texas Oncology (2016 – 2022)
• US Oncology Pharmaceutical & Therapeutics Committee (2008 – 2022)